GOP House Chairs Seek Interviews with ActBlue Board Members Over Misconduct Allegations
Republican chairs of three House committees are requesting voluntary transcribed interviews with five members of ActBlue’s board of directors as part of an expanding probe into the Democratic fundraising platform’s handling of foreign donations. The letters, reviewed by Fox News Digital, give board members until June 16 to comply and request documents related to their involvement in ActBlue’s response to donor fraud allegations. The committees accuse ActBlue of stonewalling by withholding subpoenaed documents and failing to be transparent after learning about potential misrepresentation of facts to Congress. Central to the concerns is reporting from The New York Times that ActBlue’s former outside counsel, Covington & Burling, warned CEO Regina Wallace-Jones in early 2025 that she may have given misleading comments about how the platform screened potentially illegal contributions. ActBlue’s new outside counsel later acknowledged in a June 2025 letter that the organization strengthened certain donor-screening procedures months after the board learned of the concerns. The probe also examines the board’s response to high-profile departures and alleged retaliation, including an ActBlue lawyer who had his network access cut off after warning the board about legal jeopardy. Two ActBlue unions warned the board about a “growing pattern of volatility and toxicity” and asserted that legal and compliance functions had been compromised. ActBlue has denied any wrongdoing and has not been criminally charged, with spokespersons previously casting the investigation as a Republican attempt to undermine the group ahead of the midterm elections.
What’s reported
GOP chairs of the House Administration, Oversight, and Judiciary committees sent letters requesting interviews with five ActBlue board members.
Board members have until June 16 to voluntarily comply.
The committees accuse ActBlue of stonewalling by withholding subpoenaed documents.
The letters state the board “may have participated in or been aware of this misconduct.”
ActBlue CEO Regina Wallace-Jones is expected to testify before the House Administration Committee on June 10.
According to The New York Times, Covington & Burling warned Wallace-Jones in early 2025 that she may have given misleading comments to Congress.
ActBlue did not immediately clarify that some screening procedures were not always followed as described to investigators.
ActBlue’s new outside counsel acknowledged in a June 2025 letter that donor-screening procedures were strengthened months after the board learned of concerns.
Kimberly Peeler-Allen, chairwoman of the ActBlue board, told The Times the organization did not issue a correction because “we weren’t going to poke the bear.”
An ActBlue lawyer had his network access cut off after warning the board about legal jeopardy, according to The Times.
Two ActBlue unions warned the board about a “growing pattern of volatility and toxicity” and asserted legal and compliance functions had been compromised.
ActBlue denies wrongdoing and has not been criminally charged.
Conflicting accounts
ActBlue has denied any wrongdoing and characterized the congressional probe as an attempt by Republicans to undermine the organization ahead of the midterm elections.
Open questions
It is unclear whether the board members will comply with the voluntary interview requests by the June 16 deadline. The source article also notes it is unclear what actions the board took in response to the allegations raised by the unions and former employees.
Key figures
Bryan Steil (R-Wis.), chairman of the House Administration Committee
James Comer (R-Ky.), chairman of the House Oversight Committee
Jim Jordan (R-Ohio), chairman of the House Judiciary Committee
Regina Wallace-Jones, CEO of ActBlue
Kimberly Peeler-Allen, chairwoman of the ActBlue board of directors
Covington & Burling, ActBlue’s former outside counsel
Sources: foxnews.com
